Global Granulocyte Macrophage Colony Stimulating Factor Market Growth 2025-2031

October 2025 | 95 pages | ID: GC076A369798EN
LP Information

Abstracts

The global Granulocyte Macrophage Colony Stimulating Factor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Granulocyte Macrophage Colony Stimulating Factor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Granulocyte Macrophage Colony Stimulating Factor players cover Aduro BioTech Inc, Amgen Inc, BriaCell Therapeutics Corp, Cold Genesys Inc, GlaxoSmithKline Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Granulocyte Macrophage Colony Stimulating Factor Industry Forecast? looks at past sales and reviews total world Granulocyte Macrophage Colony Stimulating Factor sales in 2024, providing a comprehensive analysis by region and market sector of projected Granulocyte Macrophage Colony Stimulating Factor sales for 2025 through 2031. With Granulocyte Macrophage Colony Stimulating Factor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Granulocyte Macrophage Colony Stimulating Factor industry.

This Insight Report provides a comprehensive analysis of the global Granulocyte Macrophage Colony Stimulating Factor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Granulocyte Macrophage Colony Stimulating Factor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Granulocyte Macrophage Colony Stimulating Factor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Granulocyte Macrophage Colony Stimulating Factor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Granulocyte Macrophage Colony Stimulating Factor.

This report presents a comprehensive overview, market shares, and growth opportunities of Granulocyte Macrophage Colony Stimulating Factor market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• CG-0070
• Gimsilumab
• GSK-3196165
• Lenzilumab
• MGN-1601
• Others

Segmentation by Application:

• Solid Tumor
• Lymphoma
• Kidney Cancer
• Lung Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Aduro BioTech Inc
• Amgen Inc
• BriaCell Therapeutics Corp
• Cold Genesys Inc
• GlaxoSmithKline Plc
• Humanigen Inc
• Mologen AG
• Morphotek Inc
• Sillajen Biotherapeutics
• Takeda Pharmaceutical Co Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Granulocyte Macrophage Colony Stimulating Factor market?
What factors are driving Granulocyte Macrophage Colony Stimulating Factor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Granulocyte Macrophage Colony Stimulating Factor market opportunities vary by end market size?
How does Granulocyte Macrophage Colony Stimulating Factor break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Granulocyte Macrophage Colony Stimulating Factor by Country/Region, 2020, 2024 & 2031
2.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
  2.2.1 CG-0070
  2.2.2 Gimsilumab
  2.2.3 GSK-3196165
  2.2.4 Lenzilumab
  2.2.5 MGN-1601
  2.2.6 Others
2.3 Granulocyte Macrophage Colony Stimulating Factor Sales by Type
  2.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)
  2.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2020-2025)
2.4 Granulocyte Macrophage Colony Stimulating Factor Segment by Application
  2.4.1 Solid Tumor
  2.4.2 Lymphoma
  2.4.3 Kidney Cancer
  2.4.4 Lung Disease
  2.4.5 Others
2.5 Granulocyte Macrophage Colony Stimulating Factor Sales by Application
  2.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sale Market Share by Application (2020-2025)
  2.5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
  3.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Company (2020-2025)
  3.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2020-2025)
3.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Company (2020-2025)
  3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Company (2020-2025)
  3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2020-2025)
3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Company
3.4 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Location Distribution
  3.4.2 Players Granulocyte Macrophage Colony Stimulating Factor Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR BY GEOGRAPHIC REGION

4.1 World Historic Granulocyte Macrophage Colony Stimulating Factor Market Size by Geographic Region (2020-2025)
  4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Granulocyte Macrophage Colony Stimulating Factor Market Size by Country/Region (2020-2025)
  4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Country/Region (2020-2025)
4.3 Americas Granulocyte Macrophage Colony Stimulating Factor Sales Growth
4.4 APAC Granulocyte Macrophage Colony Stimulating Factor Sales Growth
4.5 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth
4.6 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth

5 AMERICAS

5.1 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country
  5.1.1 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2020-2025)
  5.1.2 Americas Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2020-2025)
5.2 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025)
5.3 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region
  6.1.1 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2020-2025)
  6.1.2 APAC Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2020-2025)
6.2 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025)
6.3 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Country
  7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2020-2025)
  7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2020-2025)
7.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025)
7.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor by Country
  8.1.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2020-2025)
8.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025)
8.3 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor
10.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
10.4 Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Granulocyte Macrophage Colony Stimulating Factor Distributors
11.3 Granulocyte Macrophage Colony Stimulating Factor Customer

12 WORLD FORECAST REVIEW FOR GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR BY GEOGRAPHIC REGION

12.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region
  12.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Region (2026-2031)
  12.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Type (2026-2031)
12.7 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Aduro BioTech Inc
  13.1.1 Aduro BioTech Inc Company Information
  13.1.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Aduro BioTech Inc Main Business Overview
  13.1.5 Aduro BioTech Inc Latest Developments
13.2 Amgen Inc
  13.2.1 Amgen Inc Company Information
  13.2.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Amgen Inc Main Business Overview
  13.2.5 Amgen Inc Latest Developments
13.3 BriaCell Therapeutics Corp
  13.3.1 BriaCell Therapeutics Corp Company Information
  13.3.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 BriaCell Therapeutics Corp Main Business Overview
  13.3.5 BriaCell Therapeutics Corp Latest Developments
13.4 Cold Genesys Inc
  13.4.1 Cold Genesys Inc Company Information
  13.4.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Cold Genesys Inc Main Business Overview
  13.4.5 Cold Genesys Inc Latest Developments
13.5 GlaxoSmithKline Plc
  13.5.1 GlaxoSmithKline Plc Company Information
  13.5.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GlaxoSmithKline Plc Main Business Overview
  13.5.5 GlaxoSmithKline Plc Latest Developments
13.6 Humanigen Inc
  13.6.1 Humanigen Inc Company Information
  13.6.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Humanigen Inc Main Business Overview
  13.6.5 Humanigen Inc Latest Developments
13.7 Mologen AG
  13.7.1 Mologen AG Company Information
  13.7.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Mologen AG Main Business Overview
  13.7.5 Mologen AG Latest Developments
13.8 Morphotek Inc
  13.8.1 Morphotek Inc Company Information
  13.8.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Morphotek Inc Main Business Overview
  13.8.5 Morphotek Inc Latest Developments
13.9 Sillajen Biotherapeutics
  13.9.1 Sillajen Biotherapeutics Company Information
  13.9.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Sillajen Biotherapeutics Main Business Overview
  13.9.5 Sillajen Biotherapeutics Latest Developments
13.10 Takeda Pharmaceutical Co Ltd
  13.10.1 Takeda Pharmaceutical Co Ltd Company Information
  13.10.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
  13.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Takeda Pharmaceutical Co Ltd Main Business Overview
  13.10.5 Takeda Pharmaceutical Co Ltd Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Granulocyte Macrophage Colony Stimulating Factor Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Granulocyte Macrophage Colony Stimulating Factor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CG-0070
Table 4. Major Players of Gimsilumab
Table 5. Major Players of GSK-3196165
Table 6. Major Players of Lenzilumab
Table 7. Major Players of MGN-1601
Table 8. Major Players of Others
Table 9. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)
Table 11. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2020-2025) & ($ million)
Table 12. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2020-2025)
Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Granulocyte Macrophage Colony Stimulating Factor Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Granulocyte Macrophage Colony Stimulating Factor Sale Market Share by Application (2020-2025)
Table 16. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2020-2025) & ($ million)
Table 17. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2020-2025)
Table 18. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2020-2025)
Table 21. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2020-2025)
Table 23. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Producing Area Distribution and Sales Area
Table 25. Players Granulocyte Macrophage Colony Stimulating Factor Products Offered
Table 26. Granulocyte Macrophage Colony Stimulating Factor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Geographic Region (2020-2025)
Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country/Region (2020-2025)
Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2020-2025)
Table 39. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2020-2025)
Table 44. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Granulocyte Macrophage Colony Stimulating Factor
Table 56. Key Market Challenges & Risks of Granulocyte Macrophage Colony Stimulating Factor
Table 57. Key Industry Trends of Granulocyte Macrophage Colony Stimulating Factor
Table 58. Granulocyte Macrophage Colony Stimulating Factor Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Granulocyte Macrophage Colony Stimulating Factor Distributors List
Table 61. Granulocyte Macrophage Colony Stimulating Factor Customer List
Table 62. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Granulocyte Macrophage Colony Stimulating Factor Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Granulocyte Macrophage Colony Stimulating Factor Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Aduro BioTech Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 77. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 78. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Aduro BioTech Inc Main Business
Table 80. Aduro BioTech Inc Latest Developments
Table 81. Amgen Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 82. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 83. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Amgen Inc Main Business
Table 85. Amgen Inc Latest Developments
Table 86. BriaCell Therapeutics Corp Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 87. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 88. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. BriaCell Therapeutics Corp Main Business
Table 90. BriaCell Therapeutics Corp Latest Developments
Table 91. Cold Genesys Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 92. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 93. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Cold Genesys Inc Main Business
Table 95. Cold Genesys Inc Latest Developments
Table 96. GlaxoSmithKline Plc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 97. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 98. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. GlaxoSmithKline Plc Main Business
Table 100. GlaxoSmithKline Plc Latest Developments
Table 101. Humanigen Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 102. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 103. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Humanigen Inc Main Business
Table 105. Humanigen Inc Latest Developments
Table 106. Mologen AG Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 107. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 108. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. Mologen AG Main Business
Table 110. Mologen AG Latest Developments
Table 111. Morphotek Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 112. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 113. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Morphotek Inc Main Business
Table 115. Morphotek Inc Latest Developments
Table 116. Sillajen Biotherapeutics Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 117. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 118. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. Sillajen Biotherapeutics Main Business
Table 120. Sillajen Biotherapeutics Latest Developments
Table 121. Takeda Pharmaceutical Co Ltd Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors
Table 122. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolios and Specifications
Table 123. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. Takeda Pharmaceutical Co Ltd Main Business
Table 125. Takeda Pharmaceutical Co Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Granulocyte Macrophage Colony Stimulating Factor
Figure 2. Granulocyte Macrophage Colony Stimulating Factor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Granulocyte Macrophage Colony Stimulating Factor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country/Region (2024)
Figure 10. Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of CG-0070
Figure 12. Product Picture of Gimsilumab
Figure 13. Product Picture of GSK-3196165
Figure 14. Product Picture of Lenzilumab
Figure 15. Product Picture of MGN-1601
Figure 16. Product Picture of Others
Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2025
Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2020-2025)
Figure 19. Granulocyte Macrophage Colony Stimulating Factor Consumed in Solid Tumor
Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor Market: Solid Tumor (2020-2025) & (K Pcs)
Figure 21. Granulocyte Macrophage Colony Stimulating Factor Consumed in Lymphoma
Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor Market: Lymphoma (2020-2025) & (K Pcs)
Figure 23. Granulocyte Macrophage Colony Stimulating Factor Consumed in Kidney Cancer
Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Market: Kidney Cancer (2020-2025) & (K Pcs)
Figure 25. Granulocyte Macrophage Colony Stimulating Factor Consumed in Lung Disease
Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor Market: Lung Disease (2020-2025) & (K Pcs)
Figure 27. Granulocyte Macrophage Colony Stimulating Factor Consumed in Others
Figure 28. Global Granulocyte Macrophage Colony Stimulating Factor Market: Others (2020-2025) & (K Pcs)
Figure 29. Global Granulocyte Macrophage Colony Stimulating Factor Sale Market Share by Application (2024)
Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application in 2025
Figure 31. Granulocyte Macrophage Colony Stimulating Factor Sales by Company in 2025 (K Pcs)
Figure 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company in 2025
Figure 33. Granulocyte Macrophage Colony Stimulating Factor Revenue by Company in 2025 ($ millions)
Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company in 2025
Figure 35. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Geographic Region (2020-2025)
Figure 36. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Granulocyte Macrophage Colony Stimulating Factor Sales 2020-2025 (K Pcs)
Figure 38. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue 2020-2025 ($ millions)
Figure 39. APAC Granulocyte Macrophage Colony Stimulating Factor Sales 2020-2025 (K Pcs)
Figure 40. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue 2020-2025 ($ millions)
Figure 41. Europe Granulocyte Macrophage Colony Stimulating Factor Sales 2020-2025 (K Pcs)
Figure 42. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue 2020-2025 ($ millions)
Figure 43. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales 2020-2025 (K Pcs)
Figure 44. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue 2020-2025 ($ millions)
Figure 45. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2025
Figure 46. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2025)
Figure 47. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)
Figure 48. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2020-2025)
Figure 49. United States Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 50. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 51. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 52. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 53. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2025
Figure 54. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2020-2025)
Figure 55. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)
Figure 56. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2020-2025)
Figure 57. China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 58. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 59. South Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 60. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 61. India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 62. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 63. China Taiwan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 64. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2025
Figure 65. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2020-2025)
Figure 66. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)
Figure 67. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2020-2025)
Figure 68. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 69. France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 70. UK Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 71. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 72. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 73. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2020-2025)
Figure 74. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2020-2025)
Figure 75. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2020-2025)
Figure 76. Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 77. South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 78. Israel Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 79. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 80. GCC Countries Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2020-2025 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor in 2025
Figure 82. Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
Figure 83. Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor
Figure 84. Channels of Distribution
Figure 85. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Forecast by Region (2026-2031)
Figure 86. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Region (2026-2031)
Figure 87. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2026-2031)
Figure 88. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Type (2026-2031)
Figure 89. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Application (2026-2031)
Figure 90. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Application (2026-2031)